These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1354057

  • 21. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.
    Pickar D, Labarca R, Doran AR, Wolkowitz OM, Roy A, Breier A, Linnoila M, Paul SM.
    Arch Gen Psychiatry; 1986 Jul; 43(7):669-76. PubMed ID: 3718170
    [Abstract] [Full Text] [Related]

  • 22. Diurnal variation in plasma homovanillic acid in patients with schizophrenia and healthy controls.
    Duncan E, Bollini AM, Sanfilipo M, Wieland S, Angrist B, Cooper TB, Rotrosen J.
    Schizophr Res; 2006 Jan 31; 81(2-3):323-6. PubMed ID: 16181774
    [No Abstract] [Full Text] [Related]

  • 23. Differential effect of haloperidol and clozapine on plasma homovanillic acid in elderly schizophrenic patients with or without tardive dyskinesia.
    Andia I, Zumarraga M, Zabalo MJ, Bulbena A, Davila R.
    Biol Psychiatry; 1998 Jan 01; 43(1):20-3. PubMed ID: 9442340
    [Abstract] [Full Text] [Related]

  • 24. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I, Castro-Fornieles J, Deulofeu R, de la Serna E, Goti J, Salvà J, Bernardo M.
    Psychiatry Res; 2009 Jul 30; 168(2):110-8. PubMed ID: 19501918
    [Abstract] [Full Text] [Related]

  • 25. Plasma homovanillic acid, serum anti-D1 and anti-D2 receptor activity, and psychopathology in chronic schizophrenia.
    Koshikawa H, Suzuki E, Kanba S, Nibuya M, Ishizuki T, Kohno H, Kinoshita N, Shintani F, Yagi G, Nakaki T.
    Yakubutsu Seishin Kodo; 1991 Feb 30; 11(1):79-81. PubMed ID: 1679276
    [No Abstract] [Full Text] [Related]

  • 26. Evolution of plasma homovanillic acid (HVA) in chronic schizophrenic patients treated with haloperidol.
    Galinowski A, Poirier MF, Aymard N, Leyris A, Beauverie P, Bourdel MC, Loo H.
    Acta Psychiatr Scand; 1998 Jun 30; 97(6):458-66. PubMed ID: 9669519
    [Abstract] [Full Text] [Related]

  • 27. Plasma HVA in psychiatric patients: longitudinal studies.
    Javaid JI, Sharma RP, Janicak PG, Davis JM.
    Psychopharmacol Bull; 1990 Jun 30; 26(3):361-5. PubMed ID: 2274637
    [Abstract] [Full Text] [Related]

  • 28. Serum homovanillic acid levels in schizophrenic patients and normal control subjects.
    Steinberg JL, Garver DL, Moeller FG, Raese JD, Orsulak PJ.
    Psychiatry Res; 1993 Aug 30; 48(2):93-106. PubMed ID: 8416025
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
    Miura I, Takeuchi S, Katsumi A, Mori A, Kanno K, Yang Q, Mashiko H, Numata Y, Niwa S.
    J Clin Psychopharmacol; 2012 Feb 30; 32(1):106-9. PubMed ID: 22198450
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.